跳至主要内容
临床试验/CTRI/2018/08/015149
CTRI/2018/08/015149尚未招募1 期

MRI to Aid Surgical Timing Decision in Rheumatic Heart Disease - MASTD-RHD

niversity of South Australia0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Asymtpomatic moderate or severe MS (MVA <1.5cm2 or mean PG >5mmHg)
  • 2. Asymptomatic moderate-severe mixed mitral valve disease (mean PG >5).
  • 3. Asymptomatic moderate or severe MR.

排除标准

  • 1. Moderate or severe aortic regurgitation as this affects LV dilation that occurs due to mitral regurgitation.
  • 2. Any other severe valvular lesion as this would confound the data (tricuspid, pulmonary and aortic lesions that are moderate in severity are acceptable excluding moderate aortic regurgitation).
  • 3. Significant ischaemic heart disease (previous MI or known coronary stenosis >70%) as this would affect the stress test and scar results.
  • 4. LV ejection fraction < 60% or LV end-diastolic diameter (LVEDD) >44mm.
  • 5. Participant must not be part of another active trial.
  • 6. Participant must not be pregnant or lactating.
  • 7. Other severe comorbid condition, concurrent medication, or other issue that renders the participant unsuitable for participation in the study (e.g. exercise limiting lung disease).

研究者

发起方
niversity of South Australia

相似试验